Menu
Back to Journals » OncoTargets and Therapy » Volume 10
Original Research
Real-world experience of everolimus as second-line treatment in metastatic renal cell cancer after failure of pazopanib
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,976 | Dovepress* | 8,470+ | 855 | 9,325 | |
| PubMed Central* | 506 | 157 | 663 | ||
| Totals | 8,976 | 1,012 | 9,988 | ||
| *Since 6 October 2017 | |||||
View citations on PubMed Central and Google Scholar